KALV earnings: a positive outcome, +18.6%

On March 14, 2019, KalVista Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +18.6% in the window around the event. It had already run +16.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.